Gilead-backed Lyndra Therapeutics cuts nearly a quarter of staff as ph. 3 data nears mbayer Fri, 09/15/2023 – 14:14 More: Gilead-backed Lyndra Therapeutics cuts nearly a quarter of staff as ph. 3 data nears Source: fierce
read moreBristol Myers banks on 25-plus label expansions to help weather IRA, Revlimid generics and more fkansteiner Fri, 09/15/2023 – 11:30 More: Bristol Myers banks on 25-plus label expansions to help weather IRA, Revlimid generics and more Source: fierce
read moreAfter FDA setback, PTC Therapeutics’ DMD drug Translarna faces possible market withdrawal in Europe aliu Fri, 09/15/2023 – 10:54 More: After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe Source: fierce
read moreBayer CEO plots management cuts as first step in larger overhaul: Reuters zbecker Fri, 09/15/2023 – 10:39 More: Bayer CEO plots management cuts as first step in larger overhaul: Reuters Source: fierce
read moreAfter FDA experts smack down ineffective decongestant, class-action lawsuits fly kdunleavy Fri, 09/15/2023 – 09:47 More: After FDA experts smack down ineffective decongestant, class-action lawsuits fly Source: fierce
read moreThe method could also be beneficial for Parkinson’s disease and strokes More: MIT’s new technique to remotely evaluate cerebral palsy patients Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals